Literature DB >> 33980647

The Specificity of the Persistent IgM Neutralizing Antibody Response in Zika Virus Infections among Individuals with Prior Dengue Virus Exposure.

Amanda E Calvert1, Kalanthe Horiuchi2, Karen L Boroughs1, Yee T Ong1, Kimberly M Anderson1, Brad J Biggerstaff2, Mars Stone3,4, Graham Simmons3,4, Michael P Busch3,4, Claire Y-H Huang1.   

Abstract

Dengue viruses (DENV) and Zika virus (ZIKV) are related mosquito-borne flaviviruses with similar disease manifestations, vector ecologies, and geographic ranges. The ability to differentiate these viruses serologically is vital due to the teratogenic nature of ZIKV and the potential confounding of preexisting cross-reactive anti-DENV antibodies. Here, we illustrate the kinetics of the IgM neutralizing antibody (NAb) response using longitudinal samples ranging from acute ZIKV infection to late convalescence from individuals with evidence of prior DENV infection. By serially depleting antibody isotypes prior to the neutralization assay, we determined that IgM contributes predominantly to ZIKV neutralization and is less cross-reactive than the IgG NAb. The IgM NAb peaked around 14 days (95% confidence interval [95% CI], 13 to 15) and had a median duration of 257 days (95% CI, 133 to 427). These results demonstrate the persistence of IgM NAb after ZIKV infection and imply its potential role in diagnosis, vaccine evaluation, serosurveillance, and research on flavivirus-host interactions.

Entities:  

Keywords:  IgM neutralization; Zika virus; dengue virus; serology diagnostics

Mesh:

Substances:

Year:  2021        PMID: 33980647      PMCID: PMC8288270          DOI: 10.1128/JCM.00400-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Purified Inactivated Zika Vaccine Candidates Afford Protection against Lethal Challenge in Mice.

Authors:  Whitney R Baldwin; Jill A Livengood; Holli A Giebler; Janae L Stovall; Karen L Boroughs; Stephanie Sonnberg; Kelly J Bohning; Elizabeth A Dietrich; Yee Tsuey Ong; Hoang K Danh; Hetal K Patel; Claire Y-H Huang; Hansi J Dean
Journal:  Sci Rep       Date:  2018-11-07       Impact factor: 4.379

2.  Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages.

Authors:  T R Kreil; I Burger; M Bachmann; S Fraiss; M M Eibl
Journal:  Clin Exp Immunol       Date:  1997-12       Impact factor: 4.330

3.  Estimation of dengue virus IgM persistence using regression analysis.

Authors:  Harry E Prince; Jose L Matud
Journal:  Clin Vaccine Immunol       Date:  2011-10-26

Review 4.  Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere.

Authors:  Helen M Lazear; Michael S Diamond
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

5.  An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate.

Authors:  B L Innis; A Nisalak; S Nimmannitya; S Kusalerdchariya; V Chongswasdi; S Suntayakorn; P Puttisri; C H Hoke
Journal:  Am J Trop Med Hyg       Date:  1989-04       Impact factor: 2.345

6.  Duration of seminal Zika viral RNA shedding in immunocompetent mice inoculated with Asian and African genotype viruses.

Authors:  Erin M McDonald; Nisha K Duggal; Mark J Delorey; James Oksanish; Jana M Ritter; Aaron C Brault
Journal:  Virology       Date:  2019-06-20       Impact factor: 3.616

7.  Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.

Authors:  John T Roehrig; Denis Nash; Beth Maldin; Anne Labowitz; Denise A Martin; Robert S Lanciotti; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

8.  Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Jason O Velez; Amy J Lambert; Alison J Johnson; Stephanie M Stanfield; Mark R Duffy
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

9.  Prolonged persistence of IgM against dengue virus detected by commonly used commercial assays.

Authors:  Yu-Wen Chien; Zi-Hu Liu; Fan-Chen Tseng; Tzu-Chuan Ho; How-Ran Guo; Nai-Ying Ko; Wen-Chien Ko; Guey Chuen Perng
Journal:  BMC Infect Dis       Date:  2018-04-02       Impact factor: 3.090

10.  Persistent Zika Virus Infection Associated with Early Fetal Demise: A Case Report.

Authors:  Janice Pérez-Padilla; Gabriela Paz-Bailey; Dana Meaney-Delman; Kate Doyle; Joy Gary; Dania M Rodriguez; Julu Bhatnagar; Nicole M Pérez-Rodriguez; Sara Montalvo; Luisa Alvarado; Tyler M Sharp
Journal:  Open J Obstet Gynecol       Date:  2019-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.